At a glance
ClinicalIndex Comparison RecordN/ACompleted· 232 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Patient Buddy App for the Prevention of Avoidable Readmission in Cirrhosis
In Brief
An observational study for Cirrhosis. Completed, enrolled 232 participants across 1 site.
Detailed Summary
To use the PatientBuddy App to reduce 30-day avoidable readmissions in cirrhotic patients using a patient and caregiver perspective.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsCirrhosis
CountriesUnited States
CollaboratorsAgency for Healthcare Research and Quality (AHRQ)
Timeline
N/ACompletedFinished
20162017201820192020202120222023202420252026
Enrollment StartAug 2015
First PostedAug 2015
Primary CompletionJan 2017
TodayJul 2026
First PostedAug 28, 2015
Enrollment StartAug 1, 2015
Primary CompletionJan 1, 2017
TodayJul 2, 2026
Enrollment to primary: 1.4 yearsPosted 10.8 years ago